CVE-2025-13248
Management · Management Multiple Products
A high-severity vulnerability has been discovered in multiple products from the vendor Management, specifically impacting systems like the Patients Waiting Area Queue Management System.
Executive summary
A high-severity vulnerability has been discovered in multiple products from the vendor Management, specifically impacting systems like the Patients Waiting Area Queue Management System. This weakness could allow an unauthenticated attacker to bypass security controls and gain unauthorized access to sensitive information. Successful exploitation could lead to the exposure of confidential data, such as patient records, posing a significant risk to privacy and regulatory compliance.
Vulnerability
The vulnerability is an authentication bypass weakness within the application's access control mechanism. An unauthenticated remote attacker can craft a specialized request to a specific API endpoint, which fails to properly validate the user's session or privileges. By exploiting this flaw, the attacker can directly access functions and data normally restricted to authenticated, high-privilege users, leading to the unauthorized disclosure and potential modification of sensitive system data.
Business impact
This vulnerability is rated as High severity with a CVSS score of 7.3. Exploitation could have a significant negative impact on the organization, primarily through the breach of highly sensitive data, such as patient information in a healthcare context. The consequences include severe reputational damage, loss of customer trust, and potential legal and financial penalties resulting from non-compliance with data protection regulations (e.g., HIPAA). The direct operational impact could involve data integrity loss and the cost associated with incident response and recovery.
Remediation
Immediate Action: Apply the security patches provided by the vendor across all affected systems without delay. After patching, it is critical to review system and application access logs for any signs of compromise that may have occurred prior to remediation.
Proactive Monitoring: Implement enhanced monitoring on affected systems. Security teams should look for unusual access patterns to sensitive data repositories, direct API calls that bypass normal application flow, and access from unknown or suspicious IP addresses. Configure alerts for multiple failed authentication attempts followed by a successful access from the same source, which could indicate a successful bypass.
Compensating Controls: If immediate patching is not feasible, implement compensating controls to reduce the risk. This includes deploying a Web Application Firewall (WAF) with rules specifically designed to block malicious requests targeting the vulnerable components. Additionally, restrict network access to the affected application to only trusted IP ranges and enforce stricter access control policies.
Exploitation status
Public Exploit Available: false
Analyst recommendation
Given the high CVSS score and the direct threat to sensitive data, it is strongly recommended that the organization prioritizes the immediate application of the vendor-supplied security updates. The potential for a data breach involving patient or customer information presents an unacceptable risk. Although this CVE is not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog, its status should be continuously monitored, and remediation should proceed with urgency as if active exploitation is imminent.